Fri Sep 20 07:35:01 UTC 2024: ## Victory Capital Management Invests in Solventum Co. Amidst Mixed Analyst Opinions

**New York, NY** – Victory Capital Management Inc. has taken a new position in Solventum Co. (NYSE: SOLV), acquiring 22,582 shares valued at approximately $1,194,000 during the second quarter, according to a recent SEC filing. This move comes as Solventum continues to attract attention from institutional investors, with other notable players including Price T Rowe Associates Inc. MD, Mitsubishi UFJ Trust & Banking Corp, and CWM LLC all purchasing new stakes in the company earlier this year.

While the investment from Victory Capital suggests confidence in Solventum’s future, analysts remain divided in their opinions on the healthcare company. Morgan Stanley and Bank of America both lowered their target prices on SOLV, citing concerns about the company’s future prospects. However, The Goldman Sachs Group increased its target price, while Wells Fargo & Company dropped their target price but maintained an “equal weight” rating.

Overall, analysts are currently split on SOLV, with one “sell” rating and six “hold” ratings. This has resulted in a consensus “hold” rating and a target price of $58.25, according to MarketBeat.

Solventum’s recent financial performance has been positive, with the company exceeding analysts’ earnings expectations in the second quarter. Revenue also slightly surpassed estimates, demonstrating continued growth.

Despite the mixed signals from analysts, Solventum remains a company to watch. The company’s dedication to innovation and its strong financial performance could continue to attract investors in the future.

Read More